Skip to content
Disclosery

Invenomic Capital Management LP: XRAY position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Invenomic Capital Management LP on XRAY, newest first. How the timeline and the estimate are built.

Invenomic Capital Management LP held 4,909,808 XRAY shares at 2026-06-30 per its 13F-HR filed 2026-08-14.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 4,909,808 shares
    Change vs previous 13F +519,715 shares

    3.11% of the 13F portfolio, value $52,093,063.

    13F-HR 0001214659-26-010369 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 4,390,093 shares
    Change vs previous 13F -741,943 shares

    2.35% of the 13F portfolio, value $50,925,079.

    13F-HR 0001214659-26-006456 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 5,132,036 shares
    Change vs previous 13F +780,837 shares

    2.83% of the 13F portfolio, value $58,659,171.

    13F-HR 0001214659-26-001967 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 4,351,199 shares
    Change vs previous 13F +1,425,637 shares

    2.89% of the 13F portfolio, value $55,216,715.

    13F-HR 0001214659-25-016624 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 2,925,562 shares
    Change vs previous 13F +448,656 shares

    2.64% of the 13F portfolio, value $46,457,925.

    13F-HR 0001214659-25-012218 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 2,476,906 shares
    Change vs previous 13F -162,255 shares

    1.88% of the 13F portfolio, value $37,004,976.

    13F-HR 0001214659-25-007823 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 2,639,161 shares
    Change vs previous 13F +1,762,428 shares

    2.82% of the 13F portfolio, value $50,091,276.

    13F-HR 0001214659-25-002834 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 876,733 shares
    Change vs previous 13F not available

    1.31% of the 13F portfolio, value $23,724,395.

    13F-HR 0001214659-24-019131 filed by Invenomic Capital Management LP
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).